The Mortara Certified Partner program provides expert HL7 consultation to certify adherence to the HL7 annotated ECG standard used by the FDA for collection and viewing of digital ECG studies. The certification process involves validation testing of sample annotated ECG files, followed by detailed consultation on potential syntax and format errors. Upon successful correction of any issues, Mortara provides the Certified Partner a certification letter stating adherence to the HL7 standard.

Global Clinical Trials, LLC is a regional CRO, headquartered in Princeton, NJ, with full-service clinical operations in Russia, Ukraine, Bulgaria, Serbia and Romania. GCT has been performing clinical research in this growing and dynamic region since 2001, providing individualized approaches, flexible pricing, fast patient recruitment, and high quality clinical development services. Whether you are looking for full clinical support, including site selection, monitoring, project management, regulatory services, import/export, drug storage, or medical writing, or you are simply interested in a stand-alone task to address an urgent need, you can count on GCT to handle your requirements professionally and completely. GCT offers a strong understanding of both local and international regulations, as well as access to thousands of qualified sites specializing in numerous therapeutic areas. Our

DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita HealthCare Partners Inc., uses its extensive, applied database and real-world healthcare experience to assist pharmaceutical and medical device companies in the design, recruitment, and completion of clinical trials, including retrospective, prospective, and pragmatic trials. DCR has two hospital-based clinical pharmacology units with 122 beds, and has conducted Phase I-IIa trials for more than 175 client companies over the last 30 years. DCR’s Early Clinical Research group conducts trials in both healthy normal volunteers and specialty populations, with expertise in renal and hepatic clearance studies. Their integrated clinical data analysis and reporting and onsite compounding pharmacies make them a comprehensive service provider for early clinical research.

As a founding member called Cardiocore, BioTel Research was the first cardiac core lab to join the Cardiac Safety Research Consortium (CSRC). Other founding members include pharmaceutical organizations such as AstraZeneca, Daiichi-Sankyo, Eli Lilly, GSK, J&J, Pfizer, Merck, and Roche. The CSRC represents a key initial step in bringing together key constituencies to focus on cardiac safety issues during the drug development process. Using the principals of the FDA’s Critical Path Initiative, the CSRC focuses on improving the evaluative sciences, specifically in relation to cardiac safety.

AMRA is the first in the world to transform images from a rapid, 6-minute whole body MRI scan into precise, 3D-volumetric fat and muscle measurements. AMRA’s cloud-based analysis service offers precise, automated insights that have far-reaching implications for the pharmaceutical industry, academic R&D and, soon, clinical practice. AMRA was founded in 2010 as a spin-off of the Center for Medical Image Science and Visualization (CMIV), the Department of Biomedical Engineering (IMT) and the Department of Medicine and Health (IMH) at Linköping University, Sweden.

Since 2008, AG Mednet has been the quality partner of choice in over 600 global clinical trials. AG Mednet’s partnership with BioTel Research has resulted in projects with significantly reduced data queries, reduced burden on investigator sites, and increased site compliance. Our managed, global network ensures that all constituencies involved in a project are working in unison and have access to data and records in a timely fashion. Data integration with BioTel Research’s clinical trial management systems ensures that data only needs to be entered once, and that reconciliation of imaging and cardiac safety data occurs in real time. Currently, AG Mednet collects and delivers more than 40,000 exams per month coming from thousands of investigators and trial coordinators in more than 70 countries.